QuestionSBA
QuestionChoice
This describes the mechanism of metformin - a biguanide.
10024641
b
Increases insulin sensitivity and decreases liver production of glucose
QuestionChoice
This describes the mechanism of a dipeptidyl peptidase IV (DPP-4) inhibitor such as sitagliptin.
10024642
c
Prevents breakdown of endogenous incretin
QuestionChoice
Dapagliflozin is a sodium-glucose co-transporter-2 (SGLT-2) inhibitor.
10024640
a
Reduces glucose reabsorption and increase urinary glucose excretion
QuestionChoice
This is the role of injectable insulins.
10024644
e
Replaces endogenous insulin supply
QuestionChoice
This describes the mechanism of a gliclazide such as sulfonylurea
10024643
d
Stimulates insulin release from pancreas
Concept
Chapter
2693
5789
SGLT-2 inhibitors
Topic
220
Endocrine Pharmacology
17326
Which of the following statements describes the mechanism of dapagliflozin?
a